Rhapsido

Medicinal product

(Invented) name

Rhapsido

Active substance (s)

Remibrutinibas

Strength

25 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AA60, remibrutinib

Marketing authorisation holder

Novartis Europharm Ltd., Airija

Date of authorisation

2026-04-23

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Remibrutinibas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
120630	106737	1106737	lizdinė plokštelė	N30		Receptinis	EU/1/26/2024/001	Netiekiama	-	-	No	-	-
120631	106738	1106738	lizdinė plokštelė	N60		Receptinis	EU/1/26/2024/002	Netiekiama	-	-	No	-	-
120632	106739	1106739	lizdinė plokštelė	N180		Receptinis	EU/1/26/2024/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-04-23	Registruotas